V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20221264 | 20084216 | 1.78 | 101 | Neo-adjuvant (N) | 2016-03-28 | 2016-04-10 | Capecitabine + Cisplatin + RT | 2 | Y | CAPECITABINE + CISPLATIN + RT | 101599604 |
| 20221271 | 20084217 | null | 88.8 | Palliative (P) | 2015-07-14 | 2015-07-18 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101404391 |
| 20221282 | 20084218 | 1.54 | 54.8 | Palliative (P) | 2016-04-05 | 2016-04-05 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101366827 |
| 20221295 | 20084219 | null | 59 | Neo-adjuvant (N) | 2018-05-08 | 2018-09-09 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101301235 |
| 20221296 | 20084220 | 1.58 | 60.7 | null | 2018-07-04 | 2018-07-04 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100151836 |
| 20221297 | 20084221 | 1.61 | 63.3 | 03 | 2017-10-14 | 2017-10-21 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100123939 |
| 20221299 | 20084222 | null | 42.9 | Palliative (P) | 2016-07-25 | 2016-08-12 | Oxaliplatin + Raltitrexed | 2 | N | OXALIPLATIN + RALTITREXED | 100818309 |
| 20221300 | 20084223 | 1.87 | 63.7 | null | 2019-06-13 | 2019-06-20 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 101375907 |
| 20221303 | 20084224 | null | 73.7 | Neo-adjuvant (N) | null | 2019-07-07 | Enzalutamide | 2 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101312143 |
| 20221317 | 20084225 | 1.72 | 84 | Palliative (P) | 2018-09-16 | 2018-09-26 | Enzalutamide | 02 | N | ECF | 100987549 |
| 20221322 | 20084226 | 1.78 | 88.3 | Palliative (P) | 2018-07-14 | 2018-08-06 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100357075 |
| 20221324 | 20084227 | 1.7 | 51 | Palliative (P) | 2017-08-08 | 2017-08-12 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100514715 |
| 20221329 | 20084228 | 1.53 | 73.9 | Palliative (P) | 2019-10-04 | 2019-10-25 | Carboplatin AUC 2 - 5 | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100865791 |
| 20221330 | 20084229 | 1.73 | 81.9 | Curative (C) | 2018-05-15 | 2018-05-21 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100811340 |
| 20221335 | 20084230 | 1.72 | 80.3 | Curative (C) | 2018-12-07 | 2018-12-15 | Enzalutamide | 02 | Y | CETUXIMAB + OXALIPLATIN + MDG | 101312593 |
| 20221337 | 20084231 | 1.84 | 41.2 | null | 2018-04-20 | 2018-04-28 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100740314 |
| 20221338 | 20084232 | 1.54 | 82.8 | Neo-adjuvant (N) | 2019-05-28 | 2019-06-14 | Enzalutamide | 02 | N | OCTREOTIDE | 100050813 |
| 20221345 | 20084233 | null | 72.1 | null | 2019-12-31 | 2020-01-13 | Enzalutamide | 02 | null | OCTREOTIDE | 100514574 |
| 20221348 | 20084234 | 1.53 | 63.7 | Palliative (P) | 2019-03-26 | 2019-04-03 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101537685 |
| 20221354 | 20084235 | 1.57 | 74.6 | Palliative (P) | 2019-08-17 | 2019-09-04 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100897816 |
| 20221357 | 20084236 | 1.81 | 109 | Palliative (P) | 2017-03-30 | 2017-03-30 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101062158 |
| 20221364 | 20084237 | 0 | 0 | 03 | 2019-12-01 | 2019-12-01 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100743690 |
| 20221365 | 20084238 | 1.88 | 78.5 | null | 2021-04-05 | 2021-04-07 | OCTREOTIDE | 02 | null | ENZALUTAMIDE | 100501237 |
| 20221377 | 20084239 | null | 0 | null | null | 2018-04-10 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | null | CETUXIMAB + OXALIPLATIN + MDG | 100325903 |
| 20221383 | 20084240 | 1.7 | 46.8 | null | 2018-10-08 | 2018-10-14 | Enzalutamide | N | null | ECF | 100898828 |
| 20221384 | 20084241 | 1.75 | null | Palliative (P) | 2016-12-01 | 2016-12-01 | Enzalutamide | 2 | N | ECF | 101539483 |
| 20221403 | 20084242 | 1.59 | 79 | Palliative (P) | 2016-06-30 | 2016-06-30 | Enzalutamide | N | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101338853 |
| 20221409 | 20084243 | 1.69 | 64.7 | Palliative (P) | 2018-02-22 | 2018-03-09 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100543458 |
| 20221413 | 20084244 | 1.62 | 49.25 | Palliative (P) | 2018-07-17 | 2018-07-17 | Enzalutamide | N | N | ENZALUTAMIDE | 100575563 |
| 20221415 | 20084245 | 1.67 | 41.2 | Palliative (P) | 2019-01-01 | 2019-01-01 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101064252 |
| 20221421 | 20084246 | 1.74 | 71.6 | Palliative (P) | 2018-03-03 | 2018-04-02 | Cetuximab 14 day | 02 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100067523 |
| 20221425 | 20084247 | 1.58 | 85 | Palliative (P) | 2016-07-08 | 2016-07-25 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100567185 |
| 20221429 | 20084248 | 1.84 | 56.9 | Neo-adjuvant (N) | 2018-05-21 | 2018-06-21 | Enzalutamide | 02 | N | CARBOPLATIN | 100624240 |
| 20221437 | 20084249 | 1.41 | 80.1 | Palliative (P) | 2019-11-16 | 2019-12-28 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN + RT | 101617474 |
| 20221447 | 20084250 | 1.67 | 79.7 | Curative (C) | 2017-04-22 | 2017-05-22 | Enzalutamide | N | N | OCTREOTIDE | 100004194 |
| 20221449 | 20084251 | 1.72 | 82.3 | null | 2017-09-26 | 2017-10-03 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 101860827 |
| 20221450 | 20084252 | 1.69 | 55.7 | Neo-adjuvant (N) | 2018-07-10 | 2018-07-10 | Enzalutamide | N | N | CETUXIMAB | 101030491 |
| 20221452 | 20084253 | 1.61 | 80.05 | Palliative (P) | 2018-09-28 | 2018-10-06 | Enzalutamide | N | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100665251 |
| 20221466 | 20084254 | 1.57 | 65.3 | Curative (C) | 2020-05-06 | 2020-05-06 | Enzalutamide | 2 | N | CISPLATIN | 101100508 |
| 20221467 | 20084255 | 1.65 | 92.2 | Palliative (P) | 2021-08-13 | 2021-08-18 | ECF | N | N | CARBOPLATIN + GEMCITABINE | 100798036 |
| 20221481 | 20084256 | 0.65 | 96.7 | 03 | 2017-01-01 | 2017-01-02 | Enzalutamide | N | N | ECF | 100799160 |
| 20221483 | 20084257 | 1.79 | 62.2 | null | 2020-03-17 | 2020-03-25 | Enzalutamide | 02 | N | MITOMYCIN INTRAVESICULAR | 100896888 |
| 20221487 | 20084258 | null | 58 | null | 2018-05-05 | 2018-05-09 | Cetuximab 14 day | 02 | null | OXALIPLATIN + RALTITREXED | 101644064 |
| 20221496 | 20084259 | null | 66.3 | Neo-adjuvant (N) | 2016-09-06 | 2016-09-14 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100410223 |
| 20221498 | 20084260 | 1.7 | 57.5 | Palliative (P) | 2018-08-27 | 2018-08-29 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100397418 |
| 20221509 | 20084261 | 1.68 | 79.5 | Curative (C) | null | 2019-05-09 | Mitomycin Intravesical | N | Y | MITOMYCIN INTRAVESICULAR | 100706201 |
| 20221511 | 20084262 | 1.73 | 48.2 | Palliative (P) | 2017-11-17 | 2017-11-17 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101650222 |
| 20221517 | 20084263 | 1.69 | 100.6 | Neo-adjuvant (N) | 2015-09-24 | 2015-10-20 | Enzalutamide | 2 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101704854 |
| 20221520 | 20084264 | 0 | 0 | Palliative (P) | 2017-02-25 | 2017-02-25 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100786644 |
| 20221521 | 20084265 | 1.73 | null | Neo-adjuvant (N) | 2018-09-19 | 2018-09-20 | Capecitabine + Cisplatin + RT | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100485537 |